Literature DB >> 10615272

The evolution of tafenoquine--antimalarial for a new millennium?

W Peters1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10615272      PMCID： PMC1297286          DOI： 10.1177/014107689909200705

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  30 in total

1.  The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain).

Authors:  J ARNOLD; A S ALVING; R S HOCKWALD; C B CLAYMAN; R J DERN; E BEUTLER; C L FLANAGAN; G M JEFFERY
Journal:  J Lab Clin Med       Date:  1955-09

Review 2.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds.

Authors:  L A Terzian; N Stahler; A T Dawkins
Journal:  Exp Parasitol       Date:  1968-08       Impact factor: 2.011

4.  Effects of pyrimethamine, chlorguanide, and primaquine against exoerythrocytic forms of a strain of chloroquine-resistant Plasmodium falciparum from Thailand.

Authors:  R D Powell; G J Brewer
Journal:  Am J Trop Med Hyg       Date:  1967-11       Impact factor: 2.345

5.  The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax.

Authors:  R D Cooper; W K Milhous; K H Rieckmann
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Nov-Dec       Impact factor: 2.184

6.  Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.

Authors:  J H EDGCOMB; J ARNOLD; E H YOUNT; A S ALVING; L EICHELBERGER; G M JEFFERY; D EYLES; M D YOUNG
Journal:  J Natl Malar Soc       Date:  1950-12

Review 7.  A preliminary continental risk map for malaria mortality among African children.

Authors:  R W Snow; M H Craig; U Deichmann; D le Sueur
Journal:  Parasitol Today       Date:  1999-03

Review 8.  Primaquine resistance in Plasmodium vivax.

Authors:  W E Collins; G M Jeffery
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

9.  Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.

Authors:  J K Baird; H Basri; B Subianto; D J Fryauff; P D McElroy; B Leksana; T L Richie; S Masbar; F S Wignall; S L Hoffman
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

10.  Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.

Authors:  S Pukrittayakamee; S Vanijanonta; A Chantra; R Clemens; N J White
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226
View more
  11 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

Review 2.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

3.  Antimalarial activities of new pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives.

Authors:  Jian Guan; Quan Zhang; Michael O'Neil; Nicanor Obaldia; Arba Ager; Lucia Gerena; Ai J Lin
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 5.  Utility of 8-Aminoquinolines in Malaria Prophylaxis in Travelers.

Authors:  Eyal Meltzer; Eli Schwartz
Journal:  Curr Infect Dis Rep       Date:  2019-11-07       Impact factor: 3.725

Review 6.  Tafenoquine and G6PD: a primer for clinicians.

Authors:  Cindy S Chu; David O Freedman
Journal:  J Travel Med       Date:  2019-06-01       Impact factor: 8.490

7.  Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.

Authors:  M D Edstein; D A Kocisko; T G Brewer; D S Walsh; C Eamsila; B G Charles
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

8.  Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.

Authors:  Rita Capela; Ghislain G Cabal; Philip J Rosenthal; Jiri Gut; Maria M Mota; Rui Moreira; Francisca Lopes; Miguel Prudêncio
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

9.  Transplacental Transfer of Primaquine and Neurobehavioral Development of Prenatally Exposed Rats.

Authors:  Klaus M Becker; Lorenna Rosa; Manoella S B Fernandes; Rosangela R de Carvalho; Ana Cecilia X De-Oliveira; Davyson L Moreira; Francisco J R Paumgartten
Journal:  J Toxicol       Date:  2021-06-24

10.  Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.

Authors:  Geoffrey S Dow; Alan J Magill; Colin Ohrt
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.